Get the Stockscreener App
2.07
0.00%
0.00
Bioharvest Sciences Inc stock is traded at $2.07, with a volume of 33,024.
It is up +0.00% in the last 24 hours and down -25.81% over the past month.
BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. The Company has two operating segments or business units: the Products business unit and the CDMO Services business unit. In identifying these operating segments, management generally follows the Company's service lines representing its main products and services. The Products Business Unit - Nutraceuticals: Research, development, manufacturing, marketing and sales of science-based health and wellness nutraceutical solutions which are manufactured and sold as dietary supplements, functional food and beverages. The CDMO Services Business Unit - comprising a Contract Development and Manufacturing Operation that offers pharmaceuticals, cosmeceuticals, nutraceuticals, and nutritions.
See More
Previous Close:
$2.07
Open:
$2.07
24h Volume:
33,024
Relative Volume:
0.72
Market Cap:
$46.92M
Revenue:
$35.16M
Net Income/Loss:
$-11.44M
P/E Ratio:
-3.4726
EPS:
-0.5961
Net Cash Flow:
$-15.44M
1W Performance:
-19.14%
1M Performance:
-25.81%
6M Performance:
-56.60%
1Y Performance:
-77.54%
1-Day Range:
$2.02
$2.155
1-Week Range:
$2.01
$2.62
52-Week Range:
$1.82
$12.80
Bioharvest Sciences Inc Stock (BHST) Company Profile
Name
Bioharvest Sciences Inc
Sector
Industry
Phone
-
Address
-
Compare BHST vs JBS, KHC, GIS, MKC, HRL
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BHST
Bioharvest Sciences Inc
|
2.07 | 48.74M | 35.16M | -11.44M | -15.44M | -0.5961 |
JBS
Jbs Nv
|
13.65 | 43.16B | 88.25B | 1.91B | -681.64M | 1.6761 |
KHC
Kraft Heinz Co
|
25.51 | 29.09B | 24.99B | -5.76B | 3.95B | -4.863 |
GIS
General Mills Inc
|
39.20 | 20.38B | 18.42B | -85.30M | 1.63B | -0.1894 |
MKC
Mccormick Co Inc
|
54.67 | 14.24B | 7.39B | 1.63B | 1.02B | 6.0085 |
HRL
Hormel Foods Corp
|
24.54 | 13.42B | 12.22B | 466.64M | 692.94M | 0.8477 |
Bioharvest Sciences Inc Stock (BHST) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-19-26 | Initiated | Roth Capital | Buy |
| May-05-25 | Initiated | Craig Hallum | Buy |
| Dec-18-24 | Initiated | Maxim Group | Buy |
Bioharvest Sciences Inc Stock (BHST) Latest News
BioHarvest Sciences Inc. (NASDAQ:BHST) Just Reported And Analysts Have Been Cutting Their Estimates - simplywall.st
BHST Maintains Rating by Maxim Group -- Price Target Lowered to $5.00 - GuruFocus
BioHarvest Sciences Inc. Common Stock (NASDAQ: BHST) Stock Price, News & Analysis - Kalkine
BHST Maintained by Roth Capital -- Price Target Lowered to $8.00 - GuruFocus
BioHarvest at canaccord growth conference: scaling plant-cell platform By Investing.com - Investing.com Canada
BioHarvest Sciences: Patented cell culture platform secures $20–30M fragrance deal, targets $40M revenue and profitability - TradingView
BioHarvest at canaccord growth conference: scaling plant-cell platform - Investing.com
BioHarvest Sciences Inc reports results for the quarter ended June 30Earnings Summary - TradingView
BioHarvest Sciences (BHST) Q2 2026 Earnings Call Transcript - AOL.com
BioHarvest Sciences Inc (BHST) (Q2 2026) Earnings Call Highlights: Strategic Pivot to ... By GuruFocus - Investing.com Canada
BioHarvest Sciences Inc (BHST) (Q2 2026) Earnings Call Highlight - GuruFocus
BioHarvest Sciences Inc (BHST) (Q2 2026) Earnings Call Highlights: Strategic Pivot to ... - Yahoo Finance
What Could BioHarvest Sciences (NASDAQ:BHST) Quarterly Update Show? - Kalkine Media
BioHarvest Sciences Inc. Common Stock Q2 2026 Earnings Call Summary - Yahoo Finance
Earnings call transcript: BioHarvest Sciences posts smaller Q2 2026 loss By Investing.com - Investing.com Canada
BioHarvest Sciences cuts FY26 revenue guidance for CDMO and VINIA D2C - scanx.trade
Transcript : BioHarvest Sciences Inc., Q2 2026 Earnings Call, Aug 11, 2026 - marketscreener.com
BioHarvest Sciences Q2 Earnings Call Highlights - MarketBeat
BioHarvest Sciences: Secured first major CDMO contract and reaffirmed 2027 EBITDA breakeven despite revised 2026 guidance - TradingView
BioHarvest Sciences: Secured a transformative fragrance CDMO contract, driving revenue growth and 2027 EBITDA breakeven - TradingView
Earnings call transcript: BioHarvest Sciences posts smaller Q2 2026 loss - Investing.com
BioHarvest Sciences shares surge 11% after major fragrance manufacturing deal - Yahoo Finance
BioHarvest Sciences shares surge 11% on major fragrance deal By Investing.com - Investing.com Canada
BioHarvest Sciences Inc. (BHST) Reports Q2 Loss, Lags Revenue Estimates - Yahoo Finance
BioHarvest secures fragrance manufacturing deal worth $20-30M By Investing.com - Investing.com Australia
BioHarvest secures first CDMO manufacturing dea... - Pluang
BioHarvest Sciences shares surge 11% on major fragrance deal - Investing.com
BioHarvest Sciences: Q2 revenue up 3.8% to $8.8M; first CDMO deal signed; full-year guidance revised downward - TradingView
BioHarvest secures fragrance manufacturing deal worth $20-30M - Investing.com
BioHarvest Sciences Announces Q2 2026 Financial Results and Secures Inaugural CDMO Fragrance Manufacturing Contract for 20-Ton Production - Kalkine Media
BioHarvest Sciences Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
BioHarvest Sciences Lands Exclusive 20-Tonne Rare Fragrance Production Deal Worth $20–$30 Million - Kalkine Media
BioHarvest posts higher Q2 revenue, secures manufacturing deal for premium fragrance compound - Proactive financial news
Bioharvest Sciences Inc (BHST) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
BioHarvest Sciences Announces Uplisting to the Nasdaq Global Market - 富途牛牛
BioHarvest Sciences (BHST) Holds Steady at $2.26, Trapped Between $2.15 Support and $2.37 ResistanceRetail Volume - dars.gov.et
Enterprise value to EBIT forward of BioHarvest Sciences, Inc. – FWB:8MV0 - TradingView
Price to sales forward of BioHarvest Sciences, Inc. – MUN:8MV0 - tradingview.com
BioHarvest Sciences CEO to Present at Canaccord Genuity 46th Annual Growth Conference in Boston - kalkine.ca
BioHarvest Sciences CEO to present at Canaccord Genuity conference - Proactive financial news
BioHarvest Sciences to Unveil Q2 2026 Financial Results on August 11, 2026 - Kalkine Media
BioHarvest CEO to discuss first 100 days and 2026 growth plan - Stock Titan
BioHarvest to report Q2 2026 earnings and host a conference call on August 11 - Pluang
Bioharvest Sciences Inc (BHST) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Bioharvest Sciences Inc (BHST) Balance Sheet - TradingKey
Bioharvest Sciences Inc (BHST) Cash Flow - TradingKey
Bioharvest Sciences Inc (BHST) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
BioHarvest Sciences, Inc. Revenue Breakdown – LSX:A40C6G - TradingView
BioHarvest Sciences Inc. Revenue Breakdown – NASDAQ:BHST - TradingView
Bioharvest Sciences Inc (BHST) Income Statement - TradingKey
Bioharvest Sciences Inc (BHST) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Bioharvest Sciences Inc Stock (BHST) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.49%
2.54%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):